Boston Financial Mangement LLC Has $30.41 Million Holdings in Ryan Specialty Holdings, Inc. (NYSE:RYAN)

Boston Financial Mangement LLC boosted its position in shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report) by 4.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 473,916 shares of the company's stock after acquiring an additional 21,427 shares during the quarter. Boston Financial Mangement LLC owned 0.18% of Ryan Specialty worth $30,406,000 at the end of the most recent reporting period.

A number of other large investors have also recently added to or reduced their stakes in the company. Hollencrest Capital Management bought a new stake in Ryan Specialty in the 3rd quarter valued at $25,000. Assetmark Inc. bought a new position in shares of Ryan Specialty in the third quarter valued at about $34,000. Principal Securities Inc. lifted its stake in shares of Ryan Specialty by 164.7% during the 4th quarter. Principal Securities Inc. now owns 667 shares of the company's stock worth $43,000 after buying an additional 415 shares during the last quarter. Quarry LP boosted its holdings in shares of Ryan Specialty by 109.3% during the 3rd quarter. Quarry LP now owns 808 shares of the company's stock worth $54,000 after buying an additional 422 shares during the period. Finally, Signaturefd LLC grew its stake in Ryan Specialty by 12.3% in the 3rd quarter. Signaturefd LLC now owns 1,347 shares of the company's stock valued at $89,000 after buying an additional 148 shares during the last quarter. Institutional investors and hedge funds own 84.82% of the company's stock.

Insider Transactions at Ryan Specialty

In related news, Director Nicholas Dominic Cortezi sold 31,409 shares of Ryan Specialty stock in a transaction that occurred on Wednesday, January 29th. The shares were sold at an average price of $65.64, for a total transaction of $2,061,686.76. Following the sale, the director now directly owns 2,697 shares of the company's stock, valued at approximately $177,031.08. The trade was a 92.09 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. In the last quarter, insiders sold 316,451 shares of company stock valued at $20,907,793. Corporate insiders own 11.10% of the company's stock.

Ryan Specialty Price Performance

RYAN traded down $3.05 on Friday, hitting $65.55. 2,425,852 shares of the stock were exchanged, compared to its average volume of 990,822. The firm has a market capitalization of $17.16 billion, a price-to-earnings ratio of 85.13, a PEG ratio of 1.21 and a beta of 0.72. The company has a debt-to-equity ratio of 2.40, a current ratio of 1.01 and a quick ratio of 1.01. Ryan Specialty Holdings, Inc. has a 12 month low of $45.72 and a 12 month high of $75.97. The business has a 50-day moving average of $65.57 and a two-hundred day moving average of $67.26.

Ryan Specialty (NYSE:RYAN - Get Free Report) last issued its quarterly earnings results on Thursday, February 20th. The company reported $0.45 earnings per share for the quarter, missing analysts' consensus estimates of $0.47 by ($0.02). The firm had revenue of $663.53 million for the quarter, compared to the consensus estimate of $658.80 million. Ryan Specialty had a return on equity of 47.90% and a net margin of 10.31%. Sell-side analysts forecast that Ryan Specialty Holdings, Inc. will post 1.82 EPS for the current fiscal year.

Ryan Specialty Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, March 18th. Stockholders of record on Tuesday, March 4th will be paid a $0.12 dividend. This is a positive change from Ryan Specialty's previous quarterly dividend of $0.11. The ex-dividend date is Tuesday, March 4th. This represents a $0.48 annualized dividend and a dividend yield of 0.73%. Ryan Specialty's dividend payout ratio (DPR) is presently 57.14%.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on the stock. Royal Bank of Canada cut their price objective on shares of Ryan Specialty from $73.00 to $72.00 and set a "sector perform" rating for the company in a research report on Friday. Barclays lifted their price target on Ryan Specialty from $76.00 to $88.00 and gave the stock an "overweight" rating in a report on Thursday, November 21st. Morgan Stanley started coverage on Ryan Specialty in a report on Thursday, December 5th. They issued an "overweight" rating and a $90.00 price objective on the stock. Wells Fargo & Company lifted their target price on Ryan Specialty from $64.00 to $69.00 and gave the stock an "equal weight" rating in a report on Friday. Finally, Keefe, Bruyette & Woods decreased their price target on shares of Ryan Specialty from $77.00 to $76.00 and set an "outperform" rating on the stock in a research note on Friday. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and six have assigned a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus target price of $74.55.

Ryan Specialty Company Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.